Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants

Study Overview
=================
Brief Summary
-----------------
The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA). Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met. Clinicians need to have a real analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.

Detailed Description
-----------------
The DS PrimeTaper implant has macro-design features that differ from its predecessor, the OsseoSpeed EV implant (AstraTech Implant System EV, Dentsply Implants, Mölndal, Sweden) with which they share a common surface and internal connection. Its macro-design has been modified through the introduction of variable thread forms and a more pronounced taper, ultimately making it more aggressive in terms of cutting ability. While its predecessor, the OsseoSpeed EV implant, has sufficient scientific support, this new system recently introduced on the market does not. All the scientific contributions that can be made will therefore be a first guide for the clinician who wishes to start using this dental implant system.

Official Title
-----------------
Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants: A Prospective Medium Term Study

Conditions
-----------------
Dental Implants

Intervention / Treatment
-----------------
* Device: Implant Treatment


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All the patients whom received at least one DS Prime Taper implant. Exclusion Criteria: When dental implant surgery is contraindicated.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 99 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients DS Prime Taper<br>Patients who receive al least one DS Prime Taper on his dental implant treatment. | Device: Implant Treatment<br>* Surgical placement of a DS Prime Taper implant and its posterior prosthesis.<br>* Other names: Implant placement;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Implant Survival Rate | Time of survival of DS Prime Taper dental implant placed | through study completion, an average of 1 year | 
| Implant Success Rate | Radiological assessment of Marginal Bone Levels around DS Prime Taper implants in function | through study completion, an average of 1 year | 
| Biological and mechanical complications events | All type of complications that may occur during implant survival | through study completion, an average of 1 year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Dental implant, Complication, DS Prime Taper